Cathepsin B-Cleavable Voriconazole Macromolecular Prodrugs for Intracellular Release
Biomacromolecules · 11.11.2026
DOI: 10.1021/acs.biomac.6c01503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 11.11.2026. Verfasst von Julien Alex und 18 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium f?r Forschung, Technologie und Raumfahrt, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Invasive aspergillosis is a life-threatening fungal infection starting in the lungs of immunocompromised patients. After inhalation, the conidia (spores) of this mold are phagocytosed by epithelial and immune cells. The fungus has developed mechanisms to survive intracellularly in phagolysosomes. This way, the conidia hide from the residual immune system and also medication for some time, as antifungal drugs need to cross two membranes, i.e., the cytoplasmic and phagolysosomal membranes. A macromolecular prodrug (MPD) has therefore been designed and successfully synthesized for the intraphagosomal delivery of voriconazole, the primary antibiotic for treatment of invasive aspergillosis. The drug was attached as a benzylazolium salt to a cathepsin B-cleavable substrate, which was then linked to an N-(2-hydroxypropyl)methacrylate-analogous polymer. The intracellular colocalization of the MPD with conidia in phagolysosomes was demonstrated, and approximately 45% of voriconazole was released within three days, demonstrating the successful linkage of azole antifungals to enzyme-cleavable substrates.
Förderung
- Bundesministerium f?r Forschung, Technologie und Raumfahrt
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Alex, J., González, K., Händel, M., Roesner, N. C., Stroe, M., Rosin, M., Bellstedt, P., Schlörer, N., Weber, C., Dietz, S., Cömert, D. N., Ulrich, H. F., Schweder, H., Tröger-Görler, S., Heinekamp, T., Guerrero-Sanchez, C., Orasch, T., Schubert, U. S., & Brakhage, A. A. (2026). Cathepsin B-Cleavable Voriconazole Macromolecular Prodrugs for Intracellular Release. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c01503
Vancouver
Alex J, González K, Händel M, Roesner NC, Stroe M, Rosin M, et al. Cathepsin B-Cleavable Voriconazole Macromolecular Prodrugs for Intracellular Release. Biomacromolecules. 2026. doi:10.1021/acs.biomac.6c01503
BibTeX
@article{Alex2026,
author = {Alex, Julien and González, Katherine and Händel, Melanie and Roesner, Nicole C. and Stroe, Maria and Rosin, Maira and Bellstedt, Peter and Schlörer, Nils and Weber, Christine and Dietz, Sophie and Cömert, Derya Nur and Ulrich, Hans Felix and Schweder, Henrik and Tröger-Görler, Sophie and Heinekamp, Thorsten and Guerrero-Sanchez, Carlos and Orasch, Thomas and Schubert, Ulrich S. and Brakhage, Axel A.},
title = {Cathepsin B-Cleavable Voriconazole Macromolecular Prodrugs for Intracellular Release},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.6c01503}
}
EUVIMED